To rule out the possibility of spread from an internal tumor, CDX-2 (negative in EMPD and positive in colon cancer) and uroplakin-III (negative in EMPD and positive in urothelial carcinoma) are helpful. This evidence concerns the gene CDX2 and malignant colon neoplasm.